Evidence map›Paper›PMID 28054559›Full record

ArticleScientific reports2017

The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells.

Jialing Rao, Zengchun Ye, Hua Tang, Cheng Wang, Hui Peng, Weiyan Lai, Yin Li, Wanbing Huang, Tanqi Lou

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jialing RaoDivision of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China.
Zengchun YeDivision of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China.
Hua TangDivision of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China.
Cheng WangDivision of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China.
Hui PengDivision of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China.
Weiyan LaiDivision of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China.
Yin LiDivision of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China.
Wanbing HuangDivision of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China.
Tanqi LouDivision of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China.
Sun Yat-sen University · CNThird Affiliated Hospital of Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A recent study demonstrated that advanced glycation end products (AGEs) play a role in monocyte infiltration in mesangial areas in diabetic nephropathy. The Ras homolog gene family, member A Rho kinase (RhoA/ROCK) pathway plays a role in regulating cell migration. We hypothesized that the RhoA/ROCK pathway affects adhesion and inflammation in endothelial cells induced by AGEs. Rat glomerular endothelial cells (rGECs) were cultured with AGEs (80 μg/ml) in vitro. The ROCK inhibitor Y27632 (10 nmol/l) and ROCK1-siRNA were used to inhibit ROCK. We investigated levels of the intercellular adhesion molecule 1 (ICAM-1) and monocyte chemoattractant protein1 (MCP-1) in rGECs. Db/db mice were used as a diabetes model and received Fasudil (10 mg/kg/d, n = 6) via intraperitoneal injection for 12 weeks. We found that AGEs increased the expression of ICAM-1 and MCP-1 in rGECs, and the RhoA/ROCK pathway inhibitor Y27632 depressed the release of adhesion molecules. Moreover, blocking the RhoA/ROCK pathway ameliorated macrophage transfer to the endothelium. Reduced expression of adhesion molecules and amelioration of inflammatory cell infiltration in the glomerulus were observed in db/db mice treated with Fasudil. The RhoA/ROCK pathway plays a role in adhesion molecule expression and inflammatory cell infiltration in glomerular endothelial cells induced by AGEs.

Indexed as

1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAmidesAnimalsCell AdhesionCell MovementCells, CulturedChemokine CCL2Diabetic NephropathiesDisease Models, AnimalEndothelial CellsGlycation End Products, AdvancedInflammationIntercellular Adhesion Molecule-1Kidney GlomerulusMiceMice, Mutant Strains1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAmidesCcl2 protein, ratChemokine CCL2fasudilGlycation End Products, AdvancedIntercellular Adhesion Molecule-1Protein Kinase InhibitorsPyridinesrhoA GTP-Binding Proteinrho-Associated KinasesRNA, Small InterferingROCK1 protein, ratY 27632

Identifiers

PMID28054559
PMCPMC5215591
OpenAlexW2568281416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.